Marcus Heinl1 and Stephen Lock2
1SCIEX, Germany; 2SCIEX, UK
Published date: April 2, 2024
Before CE-SDS can be used to study the heavy and light chain fragments of antibody samples, proteins must be denatured in the presence of a reducing reagent. Historically, 2- mercaptoethanol (B-ME) has been used for this purpose, but its high vapor pressure, toxicity and odor can be challenging. For this reason, many scientists have switched to dithiothreitol (DTT), because it can be used at a lower concentration2 than B-ME and is easier to handle. However, DTT can also form a complex that might cause an interference peak in electropherograms.
According to a recent paper, iodoacetamide (IAM) can be used to remove these DTT complexes3. Here, we describe a single-step process for removing DTT complexes by adding IAM after sample reduction.
Sample preparation: The IgG control sample (90 µL, 150 kDa reference protein at 1 mg/mL in SDS sample buffer) from the SCIEX IgG Purity and Heterogeneity kit (P/N A10663) was mixed with DTT (500mM, 10 min, 70°C). The samples were spun (10 s, 3,000 rpm) and IAM was added at various volumes (250mM, 0–30 µL) so that the IAM was either the same, double, or triple the mM concentration of DTT in the sample (Figure 1). The samples were vortex mixed (30 s) and the vials were kept at room temperature in the dark (150 min).
Figure 1. A comparison of using different ratios of DTT and IAM in the preparation of a CE-SDS sample. All samples were injected and separated under identical conditions.
CE-SDS separation method: Samples were separated using a PA 800 Plus system from SCIEX. Before samples were tested, a bare fused silica capillary (length 30.2 cm, effective length 20 cm, 50 µm ID) from SCIEX (P/N 338451) was conditioned using the pre-installed HR-IgG Purity conditioning method. The capillary was then filled with SDS gel buffer from the SCIEX IgG Purity and Heterogeneity kit (P/N A10663). Samples were injected electrokinetically (20 s, 5 kV) and analyzed using the standard CE-SDS HR-IgG purity separation method, where the sample was separated using reverse polarity (30 min, 15 kV, 1-min ramp) at 25°C.
At the end of a batch, the HR-IgG purity shutdown method was run.
CE detection: Molecule peaks were detected using PDA detection by UV adsorption at 220 nm using a 200 x 100 µm aperture and a data sampling rate of 4 Hz.
CE data processing: Data were collected using the PA 800 Plus system and 32 Karat software from SCIEX.
In recent years, DTT has become the reagent of choice over B- ME for breaking disulfide bridges of proteins2,4 . In excess, DTT forms a hydrogen-bonded complex that can interfere with the electropherograms of a reduced antibody. These complexes often have a large hydrodynamic radius, migrating between the nonglycosylated and glycosylated heavy chain.
IAM is often used as an alkylating reagent in the preparation of tryptic digests for proteomic analysis. It forms S-carboxyamidomethyl derivatives, 5 liberating iodine in an irreversible reaction. When IAM is mixed with DTT, it disrupts the hydrogen bonds by reacting with the thiol groups of the DTT. DTT has 2 thiol groups, so IAM needs to be present in at least a 2:1 ratio with DTT to effectively disrupt the complex.
When a sample blank was prepared with sample buffer containing DTT (10mM concentration), an interfering complex peak was observed at the same migration time region as a heavy chain fragment of an antibody. This peak was removed when IAM was added at a 2:1 ratio with DTT (Figure 2).
Figure 2. Comparison of 2 blank injections showing the presence of a DTT complex peak between 19- and 20-min. Panel A shows a sample solvent blank containing DTT only. Panel B shows a sample solvent blank containing 2:1 (v/v) IAM/DTT.
This interference peak was again observed in a control IgG sample that was denatured with DTT. By adding IAM in excess— 3:1 (v/v) IAM/DTT—the interference peak was removed, improving the separation of the non-glycosylated and glycosylated heavy chain (Figure 3).
Figure 3. The effect of adding IAM on the removal of the interference of the DTT complex in the electropherogram. Panel A shows the use of only DTT in the sample preparation. Panel B shows the use of 3:1 (v/v) IAM/DTT for sample preparation.